FN2 Earnings Intelligence

AstraZeneca PLC earnings overview

Latest AstraZeneca PLC (AZN) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

Next reportAstraZeneca PLC reports Tuesday, Feb 9, 2027 · Before market openConsensus EPS $2.41 · consensus revenue $16.66B
AZN FY2026 Q3 · Calendar Q4 2026

AstraZeneca PLC

AstraZeneca's current results support a constructive growth narrative: established franchises are growing, the pipeline is advancing, and new launches and restructuring are intended to support longer-term expansion. The thesis remains dependent on execution, pricing, regulatory outcomes and the ability to offset loss-of-exclusivity pressure.

EPS surprise+7.3%
Market move+7.0%

Get the AZN recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.